Capitalizing R&D - Webcast
![Capitalizing R&D - Webcast - Templarket - Business Templates Marketplace]()
![Capitalizing R&D - Webcast - Templarket - Business Templates Marketplace]()
![Capitalizing R&D - Webcast - Templarket - Business Templates Marketplace]()
![Capitalizing R&D - Webcast - Templarket - Business Templates Marketplace]()
![Capitalizing R&D - Webcast - Templarket - Business Templates Marketplace]()
R&D is really capital expenditures (for technology and pharmaceutical companies) but accountants treat it as operating expenses. In this webcast, I look at the process of capitalizing R&D and how it affects earnings and reinvestment rates.
I use Microsoft to illustrate the process.
The spreadsheet converts R&D expenses from operating to capital expenses. It makes the appropriate adjustments to operating income, net income, the book value of assets and the book value of equity.
(It can also be used to convert other intangible assets, such as human capital, into capital invested.
Note: this model is being shared with the authorization of Professor Aswath Damodaran from NYU Stern Business School (www.damodaran.com)
I use Microsoft to illustrate the process.
The spreadsheet converts R&D expenses from operating to capital expenses. It makes the appropriate adjustments to operating income, net income, the book value of assets and the book value of equity.
(It can also be used to convert other intangible assets, such as human capital, into capital invested.
Note: this model is being shared with the authorization of Professor Aswath Damodaran from NYU Stern Business School (www.damodaran.com)
